Ceftriaxone Injection, USP 2000 mg (Ceftriaxone (Ceftriaxone Sodium) SOLUTION) 2000 MG

Ceftriaxone Injection, USP 2000 MG is a broad-spectrum antibiotic solution used for treating bacterial infections. This intravenous medication is manufactured by Baxter Corporation in Canada.

Strength

2000 MG

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ceftriaxone Injection, USP 2000 MG is commonly used to treat a variety of bacterial infections. It is often prescribed for conditions such as pneumonia, meningitis, and sepsis. This antibiotic works by stopping the growth of bacteria, making it effective for what is ceftriaxone used for in severe infections.

Side Effects

Common effects of ceftriaxone injection may include mild diarrhea, nausea, or rash. Some individuals might experience more severe reactions, such as allergic responses or changes in blood cell counts. It is important to monitor for any unusual symptoms while using this medication.

Precautions & Warnings

Ceftriaxone Injection should be handled with care, ensuring proper sterile techniques during administration. It is crucial to inform healthcare providers about any known allergies or medical conditions before use. This medication should be stored and used as directed to maintain its effectiveness.

Avoid Interactions

Ceftriaxone may interact with other medications, including blood thinners and certain antibiotics. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the body's response to ceftriaxone.

Frequently Asked Questions

Ceftriaxone injection is used to treat a wide range of bacterial infections, including pneumonia, meningitis, and sepsis.

Ceftriaxone injection is administered intravenously, typically in a clinical setting by a healthcare professional.

Common side effects may include mild diarrhea, nausea, or rash. Severe reactions are less common but possible.

Ceftriaxone may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Ceftriaxone Injection, USP 2000 MG is manufactured by Baxter Corporation in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.